A fourteen-day treatment of typhoid carriers in Hong Kong with trimethoprim-sulphamethoxazole.
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy*; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006723:Hong Kong; D006801:Humans; D008297:Male; D008875:Middle Aged; D010403:Penicillin Resistance; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy*
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D000667:Ampicillin; D014295:Trimethoprim; D013420:Sulfamethoxazole